GENETIC MARKERS AND OUTCOME IN THE CLL14 TRIAL OF THE...

HemaSphere 2019 / 06 Vol. 3

GENETIC MARKERS AND OUTCOME IN THE CLL14 TRIAL OF THE GCLLSG COMPARING FRONT LINE OBINUTUZUMAB PLUS CHLORAMBUCIL OR VENETOCLAX IN PATIENTS WITH COMORBIDITY

Tausch, E., Bahlo, J., Robrecht, S., Schneider, C., Bloehdorn, J., Schrell, S., Galler, C., Al-Sawaf, O., Fink, A.-M., Eichhorst, B., Kreuzer, K.-A., Tandon, M., Humphrey, K., Jiang, Y., Schary, W., L
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
3
Journal:
HemaSphere
DOI:
10.1097/01.hs9.0000558640.93333.00
Date:
June, 2019
File:
PDF, 335 KB
2019
Conversion to is in progress
Conversion to is failed